(Q38126427)

29 August 2017

Crimean-Congo hemorrhagic fever: an overview (English)

1 reference

Crimean-Congo hemorrhagic fever

29 August 2017

1 reference

Serkan Oncü

1

1 reference

29 August 2017

22 July 2013

1 reference

29 August 2017

1 reference

29 August 2017

28

1 reference

29 August 2017

4

1 reference

29 August 2017

193-201

1 reference

https://scigraph.springernature.com/pub.10.1007/s12250-013-3327-4

29 August 2017

0 references

cites work

Evolution of Crimean-Congo Hemorrhagic Fever virus

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

An update on crimean congo hemorrhagic Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Serodiagnosis of Crimean-Congo haemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo Hemorrhagic Fever Virus Genomics and Global Diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

The complete genome sequence of a Crimean-Congo Hemorrhagic Fever virus isolated from an endemic region in Kosovo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Reactive hemophagocytic lymphohistiocytosis and Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo haemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Treatment of Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean Congo-haemorrhagic fever treated with oral ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Exotic emerging viral diseases: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

A clear and present danger: tick-borne diseases in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Importation of Hyalomma marginatum, vector of Crimean-Congo haemorrhagic fever virus, into the United Kingdom by migratory birds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo haemorrhagic fever in Eurasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

21 January 2018

Viral hemorrhagic fevers

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Cytokine levels in Crimean-Congo hemorrhagic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Antigen-capture enzyme-linked immunosorbent assay for the diagnosis of crimean-congo hemorrhagic fever using a novel monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Infections due to Toscana virus, West Nile virus, and other arboviruses of interest in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo hemorrhagic fever virus in various ixodid tick species from a highly endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo hemorrhagic fever in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Diagnostic assays for Crimean-Congo hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Epidemiological survey of Crimean-Congo hemorrhagic fever virus in Yunnan, China, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Crimean-Congo hemorrhagic fever in Iran and neighboring countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3327-4

Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study

21 January 2018

1 reference

12 December 2020

Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo

1 reference

12 December 2020

Crimean-Congo hemorrhagic fever

1 reference

12 December 2020

Trends of major disease outbreaks in the African region, 2003-2007.

1 reference

12 December 2020

Crimean-Congo hemorrhagic fever.

1 reference

12 December 2020

A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever.

1 reference

12 December 2020

Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR.

1 reference

12 December 2020

Comparison of methods for isolation and titration of Crimean-Congo hemorrhagic fever virus

1 reference

12 December 2020

Use of RT-PCR and enzyme immunoassays for the specific diagnosis of Crimean hemorrhagic fever

1 reference

12 December 2020

Crimean-Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in 2008.

1 reference

12 December 2020

Crimean Congo hemorrhagic fever: requires vigilance and not panic.

1 reference

12 December 2020

Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever

1 reference

12 December 2020

Treatment and prophylaxis with ribavirin for Crimean-Congo Hemorrhagic Fever--is it effective?

1 reference

12 December 2020

Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China.

1 reference

12 December 2020

Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions.

1 reference

12 December 2020

Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever

1 reference

12 December 2020

The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.

1 reference

12 December 2020

Possible horizontal transmission of crimean-congo hemorrhagic Fever virus from a mother to her child

1 reference

12 December 2020

Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin

1 reference

12 December 2020

Crimean-Congo hemorrhagic fever in Iran and neighboring countries

1 reference

12 December 2020

10.1007/S12250-013-3327-4

Identifiers

DOI

1 reference

PubMed ID

23913177

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23913177